GSK PLC (GSK)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
1,822.50p
Buy
1,823.00p
3.50p (+0.19%)
Prices updated at 12 Dec 2025, 17:15 GMT
| Prices minimum 15 mins delay
Prices in GBX
GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 71.16 |
| 2023 | 71.76 |
| 2022 | 67.42 |
| 2021 | 66.95 |
| 2020 | 67.44 |
| 2019 | 64.85 |
| 2018 | 66.77 |
| 2017 | 65.74 |
| 2016 | 66.69 |
| 2015 | 62.99 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 2.35 |
| 2024 | 1.78 |
| 2023 | 2.01 |
| 2022 | 1.52 |
| 2021 | 2.44 |
| 2020 | 1.97 |
| 2019 | 2.69 |
| 2018 | 2.45 |
| 2017 | 2.17 |
| 2016 | 2.88 |
| 2015 | 2.80 |
Price/Forward earnings (YTD)
9.48
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 4.35 |
| 2023 | 8.27 |
| 2022 | 21.48 |
| 2021 | 5.50 |
| 2020 | 7.18 |
| 2019 | 6.74 |
| 2018 | 6.33 |
| 2017 | 2.65 |
| 2016 | 1.62 |
| 2015 | 17.90 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 4.35 |
| 2023 | 4.42 |
| 2022 | 5.68 |
| 2021 | 5.25 |
| 2020 | 5.51 |
| 2019 | 6.99 |
| 2018 | 15.36 |
| 2017 | - |
| 2016 | 52.56 |
| 2015 | 10.45 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.